NCT03495869
- Conditions
- Chemically-Induced Disorders, Cocaine Use Disorder, Healthy Controls, +6 more
- Locations
-
- VCU Institute for Drug and Alcohol Studies Richmond, Virginia, United States
Clinical trial condition
Opioid-use Disorder
Explore clinical trials studying Opioid-use Disorder. Study availability and eligibility vary by location and protocol.
200 public trials
16 recruiting studies
Opioid-use Disorder trial results
NCT03398265
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- DOC Community Field Office Auburn, Washington, United States
- DOC Community Field Office Burien, Washington, United States
- DOC Community Field Office Federal Way, Washington, United States
- DOC Community Field Office Kent, Washington, United States
NCT04530591
- Conditions
- Chemically-Induced Disorders, Drug Misuse, Drug Overdose, +9 more
- Locations
-
- Prevention Point Philadelphia Philadelphia, Pennsylvania, United States
NCT04417738
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +9 more
- Locations
-
- MindLight, LLC Newton Highlands, Massachusetts, United States
NCT04340622
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- McLean Hospital Belmont, Massachusetts, United States
- MindLight, LLC Newton Highlands, Massachusetts, United States
NCT04083209
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
- Locations
-
- IU Methodist Hospital Indianapolis, Indiana, United States
NCT03861338
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Substance Treatment Research Service (STARS) of Columbia University New York, United States
NCT03279562
- Conditions
- Chemically-Induced Disorders, Harmful; Use, Alcohol, Mental Disorders, +4 more
- Locations
-
- Yale University, Department New Haven, Connecticut, United States
NCT04448015
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
- Locations
-
- Eastern Utah Women's Health LLC Price, Utah, United States
Completed
Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
NCT03169816
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Substance Treatment and Research Service (STARS), Columbia University New York, United States